ArticleScientific reports2025
Deep learning model for early acute lymphoblastic leukemia detection using microscopic images.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Incorporating artificial intelligence into morphological diagnosis of acute leukemias: Current landscape, challenges and prospects (Review).Oncology reports · 2026Review
- Optimized deep learning ensemble using Fast Osprey algorithm for accurate lymphoblastic leukemia detection.Frontiers in medicine · 2026Article
- Secure pulmonary diagnosis using transformer-based approach to X-ray classification with KL divergence optimization.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer of bone marrow is classified as Acute Lymphoblastic Leukemia (ALL), an abnormal growth of lymphoid progenitor cells. It affects both children and adults and is the most predominant form of infantile cancer. Currently, there has been significant growth in the identification and therapy of acute lymphoblastic leukemia. Therefore, a method is required that is capable to accurately assessing risk by an appropriate treatment strategy that takes into account all relevant clinical, morphological, cytogenetic, and molecular aspects. However, to enhance survival and quality of life for those afflicted by this aggressive haematological malignancy, more research and clinical trials are required to address the issues associated with resistance, relapse, and long-term toxicity. Consequently, a deep optimized Convolutional Neural Network (CNN) has been proposed for the early diagnosis and detection of ALL. The design of the deep optimized CNN model consisted of five convolutional blocks with thirteen convolutional layers and five max pool layers. The proposed deep optimized CNN model is tuned using the hyperparameters such as 30 epochs, batch size 32 and optimizers, namely Adam and Adamax. Out of the two optimizers, the proposed deep optimized CNN model has outperformed using Adam optimizer with the points of accuracy and precision as 0.96 and 0.95, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.